{
  "cells": [
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "view-in-github",
        "colab_type": "text"
      },
      "source": [
        "<a href=\"https://colab.research.google.com/github/christophergaughan/progenitor-glycosylation-scanner/blob/main/fda_therapeutics_validation.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "header_cell"
      },
      "source": [
        "# FDA Therapeutics Glycosylation Validation (v3)\n",
        "## AntibodyML Consulting LLC - Enhanced Progenitor Glycosylation Scanner\n",
        "\n",
        "### v3 Methodology Enhancements:\n",
        "1. **AntPack IMGT Numbering** - Colab-friendly, precise position mapping\n",
        "2. **X-Position Efficiency Scoring** - Shakin-Eshleman rules for glycosylation efficiency\n",
        "3. **NXT vs NXS Differentiation** - NXT motifs ~2.5x more likely occupied\n",
        "4. **Vernier Zone Flagging** - IMGT positions 75-88 structural risk\n",
        "5. **Occupancy Score** - Probabilistic glycosylation likelihood\n",
        "6. **RiskLevel Stratification** - CRITICAL/HIGH/MEDIUM/LOW classification\n",
        "\n",
        "---\n",
        "\n",
        "### Scientific Foundation\n",
        "\n",
        "**van de Bovenkamp et al. (2018, 2023)** demonstrated that 79-86% of Fab N-glycosylation sites originate from progenitor positionsâ€”sequences one mutation away from creating N-X-S/T motifs.\n",
        "\n",
        "**Shakin-Eshleman et al. (1996)** established that the amino acid at position X in N-X-S/T dramatically affects glycosylation efficiency, with some residues (Pro) completely blocking and others (Ser, Thr, Ala) maximizing occupancy.\n",
        "\n",
        "This scanner integrates both insights with structural context to predict actual glycosylation risk.\n",
        "\n",
        "---\n",
        "\n",
        "**Repository:** [progenitor-glycosylation-scanner](https://github.com/AntibodyML/progenitor-glycosylation-scanner)  \n",
        "**Contact:** AntibodyML Consulting LLC"
      ]
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Introduction: Bridging ML Antibody Design and Glycosylation Risk\n",
        "\n",
        "### The Problem\n",
        "\n",
        "Tools like **RFdiffusion** and other ML-based antibody design platforms are revolutionizing *de novo* antibody generation. They can produce novel sequences with remarkable speed and structural accuracy. However, these tools optimize for structure and predicted bindingâ€”they are blind to **post-translational modification liabilities**, including N-linked glycosylation in the Fab region. (Note: while such tools can *intentionally* introduce glycosylation sites as design constraints, they do not flag N-X-S/T motifs that emerge incidentally from sequence optimization.)\n",
        "\n",
        "This matters because Fab glycosylation can:\n",
        "- Alter antigen binding affinity and specificity\n",
        "- Introduce batch-to-batch heterogeneity in manufacturing\n",
        "- Trigger immunogenic responses (as documented with Cetuximab's Î±-Gal epitope)\n",
        "- Complicate analytical characterization and regulatory approval\n",
        "\n",
        "By the time these issues surface in development, significant resources have already been invested.\n",
        "\n",
        "### The Insight: Progenitor Sites\n",
        "\n",
        "The work of van de Bovenkamp *et al*.(2018, 2023) provided a crucial insight: **79-86% of Fab N-glycosylation sites in natural antibody repertoires originate from \"progenitor\" positions**â€”sequences where a single somatic hypermutation event converts a latent motif into an actual N-X-S/T sequon.\n",
        "\n",
        "This means scanning only for existing N-X-S/T motifs misses the majority of glycosylation risk. A D-X-S/T site is one Dâ†’N mutation away from becoming glycosylated. An N-X-A site is one Aâ†’S/T mutation away. In the context of therapeutic developmentâ€”or ML-generated sequences that haven't been through evolutionary selectionâ€”these progenitor sites represent latent liabilities.\n",
        "\n",
        "### Our Approach\n",
        "\n",
        "We built the **Enhanced Progenitor Glycosylation Scanner** to operationalize this insight:\n",
        "\n",
        "1. **Scan for actual N-X-S/T sites** â€” immediate, high-weight risk\n",
        "2. **Scan for progenitor sites** â€” D-X-S/T (Dâ†’N) and N-X-[A/V/I/L] (â†’S/T) â€” weighted by mutation probability\n",
        "3. **Apply Shakin-Eshleman efficiency scoring** â€” not all sequons are equal; the X-position amino acid dramatically affects occupancy\n",
        "4. **Differentiate NXT vs NXS** â€” threonine-containing motifs are ~2.5Ã— more efficiently glycosylated\n",
        "5. **Flag structural context** â€” CDR sites affect binding; Vernier zone sites (IMGT 75-88) affect VH/VL packing and can destabilize the Fab even when glycosylation doesn't directly contact antigen\n",
        "\n",
        "The result is a **risk score (0-100)** that prioritizes sequences for review before they enter the development pipeline.\n",
        "\n",
        "### This Validation\n",
        "\n",
        "The notebook below validates the scanner against **18 FDA-approved therapeutic antibodies**. This is a deliberately conservative test:\n",
        "\n",
        "- These antibodies have survived humanization, developability screening, lead optimization, and manufacturing scale-up\n",
        "- Glycosylation liabilities have largely been engineered out\n",
        "- Only **Cetuximab** retains documented Fab glycosylation (the N88 site in VH FR3 that your work highlighted)\n",
        "\n",
        "We expectâ€”and observeâ€”high specificity (few false positives) because these are **curated survivors**. The scanner's real value is not in re-screening approved drugs, but in **catching liabilities in unscreened sequences**: RFdiffusion outputs, early-stage candidates, and natural repertoire antibodies before affinity maturation introduces new sites."
      ],
      "metadata": {
        "id": "QZrLj89hbT0U"
      }
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "setup_header"
      },
      "source": [
        "## Installation and Setup"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 1,
      "metadata": {
        "id": "install_cell",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "6c215afc-9e1e-4cd0-80e6-13f681a30c07"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "ðŸ”§ Setting up Google Colab environment...\n",
            "\n",
            "ðŸ“¦ Installing core packages...\n",
            "   âœ“ Core packages installed\n",
            "\n",
            "ðŸ“¦ Installing AntPack for IMGT numbering...\n",
            "\u001b[2K     \u001b[90mâ”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”\u001b[0m \u001b[32m46.9/46.9 kB\u001b[0m \u001b[31m2.2 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[2K   \u001b[90mâ”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”â”\u001b[0m \u001b[32m15.1/15.1 MB\u001b[0m \u001b[31m64.8 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n",
            "\u001b[?25h   âœ“ AntPack installed (GPL version)\n",
            "\n",
            "âœ… Setup complete!\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# INSTALLATION - v3 Dependencies\n",
        "# ============================================================================\n",
        "\n",
        "import sys\n",
        "IN_COLAB = 'google.colab' in sys.modules\n",
        "\n",
        "if IN_COLAB:\n",
        "    print(\"ðŸ”§ Setting up Google Colab environment...\")\n",
        "    print()\n",
        "\n",
        "    # Core packages\n",
        "    print(\"ðŸ“¦ Installing core packages...\")\n",
        "    !pip install pandas numpy matplotlib seaborn scikit-learn --quiet\n",
        "    print(\"   âœ“ Core packages installed\")\n",
        "\n",
        "    # AntPack - Colab-friendly antibody numbering (GPL v0.3.8.6)\n",
        "    print(\"\\nðŸ“¦ Installing AntPack for IMGT numbering...\")\n",
        "    !pip install antpack==0.3.8.6 --quiet\n",
        "    print(\"   âœ“ AntPack installed (GPL version)\")\n",
        "\n",
        "    print(\"\\nâœ… Setup complete!\")\n",
        "else:\n",
        "    print(\"ðŸ“ Running outside Colab\")\n",
        "    print(\"   Ensure: pandas, numpy, matplotlib, seaborn, scikit-learn, antpack==0.3.8.6\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 2,
      "metadata": {
        "id": "imports_cell",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "dc0dd048-42b9-4b8e-c0f6-f96f371c2447"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "âœ“ AntPack available - using precise IMGT numbering\n",
            "âœ“ All packages loaded successfully\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# IMPORTS\n",
        "# ============================================================================\n",
        "\n",
        "import warnings\n",
        "warnings.filterwarnings('ignore')\n",
        "\n",
        "import pandas as pd\n",
        "import numpy as np\n",
        "import matplotlib.pyplot as plt\n",
        "import seaborn as sns\n",
        "from typing import List, Dict, Optional, Tuple\n",
        "from dataclasses import dataclass, field\n",
        "from enum import Enum\n",
        "from sklearn.metrics import roc_curve, auc, precision_recall_curve\n",
        "\n",
        "# AntPack for IMGT numbering\n",
        "ANTPACK_AVAILABLE = False\n",
        "try:\n",
        "    from antpack import SingleChainAnnotator\n",
        "    ANTPACK_AVAILABLE = True\n",
        "    print(\"âœ“ AntPack available - using precise IMGT numbering\")\n",
        "except ImportError:\n",
        "    print(\"âš ï¸ AntPack not available - will use approximate CDR boundaries\")\n",
        "\n",
        "print(\"âœ“ All packages loaded successfully\")"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "xposition_header"
      },
      "source": [
        "## X-Position Efficiency Database\n",
        "\n",
        "Based on **Shakin-Eshleman et al. (1996)** and subsequent studies on sequon efficiency."
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 3,
      "metadata": {
        "id": "xposition_cell",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "f4d37323-3a5f-4330-aaa3-934294c51d40"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "âœ“ X-position efficiency database loaded\n",
            "  - High efficiency X residues: S (0.9), T (0.88), A (0.85)\n",
            "  - Blocking residue: P (0.0)\n",
            "  - NXT vs NXS: NXT is 2.5x more efficient than NXS\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# X-POSITION EFFICIENCY SCORING (Shakin-Eshleman Rules)\n",
        "# ============================================================================\n",
        "# The amino acid at position X in N-X-S/T affects glycosylation efficiency\n",
        "# Values represent relative glycosylation efficiency (0-1 scale)\n",
        "# Reference: Shakin-Eshleman et al. (1996) J Biol Chem\n",
        "\n",
        "X_POSITION_EFFICIENCY = {\n",
        "    # High efficiency (>0.7)\n",
        "    'A': 0.85,  # Alanine - small, non-polar\n",
        "    'S': 0.90,  # Serine - small, polar (optimal)\n",
        "    'T': 0.88,  # Threonine - small, polar\n",
        "    'G': 0.80,  # Glycine - minimal side chain\n",
        "    'V': 0.75,  # Valine - small hydrophobic\n",
        "    'M': 0.72,  # Methionine\n",
        "\n",
        "    # Medium efficiency (0.4-0.7)\n",
        "    'I': 0.65,  # Isoleucine\n",
        "    'L': 0.60,  # Leucine\n",
        "    'F': 0.55,  # Phenylalanine - aromatic\n",
        "    'Y': 0.50,  # Tyrosine - aromatic with OH\n",
        "    'Q': 0.55,  # Glutamine\n",
        "    'N': 0.50,  # Asparagine\n",
        "    'H': 0.45,  # Histidine - charged aromatic\n",
        "    'K': 0.45,  # Lysine - positive charge\n",
        "    'R': 0.40,  # Arginine - positive charge\n",
        "    'C': 0.50,  # Cysteine\n",
        "\n",
        "    # Low efficiency (<0.4)\n",
        "    'W': 0.30,  # Tryptophan - bulky aromatic\n",
        "    'D': 0.25,  # Aspartate - negative charge\n",
        "    'E': 0.25,  # Glutamate - negative charge\n",
        "\n",
        "    # Blocking (0)\n",
        "    'P': 0.00,  # Proline - COMPLETELY BLOCKS glycosylation\n",
        "}\n",
        "\n",
        "# NXT vs NXS efficiency multiplier\n",
        "# NXT motifs are ~2.5x more efficiently glycosylated than NXS\n",
        "NXT_NXS_MULTIPLIER = {\n",
        "    'T': 1.0,   # NXT - reference\n",
        "    'S': 0.4,   # NXS - ~40% efficiency of NXT\n",
        "}\n",
        "\n",
        "def get_sequon_efficiency(x_residue: str, third_residue: str) -> float:\n",
        "    \"\"\"\n",
        "    Calculate glycosylation efficiency for N-X-S/T sequon.\n",
        "\n",
        "    Args:\n",
        "        x_residue: Amino acid at X position\n",
        "        third_residue: S or T at +2 position\n",
        "\n",
        "    Returns:\n",
        "        Efficiency score (0-1)\n",
        "    \"\"\"\n",
        "    x_efficiency = X_POSITION_EFFICIENCY.get(x_residue.upper(), 0.5)\n",
        "    st_multiplier = NXT_NXS_MULTIPLIER.get(third_residue.upper(), 0.4)\n",
        "\n",
        "    return x_efficiency * st_multiplier\n",
        "\n",
        "print(\"âœ“ X-position efficiency database loaded\")\n",
        "print(f\"  - High efficiency X residues: S ({X_POSITION_EFFICIENCY['S']}), T ({X_POSITION_EFFICIENCY['T']}), A ({X_POSITION_EFFICIENCY['A']})\")\n",
        "print(f\"  - Blocking residue: P ({X_POSITION_EFFICIENCY['P']})\")\n",
        "print(f\"  - NXT vs NXS: NXT is {1/NXT_NXS_MULTIPLIER['S']:.1f}x more efficient than NXS\")"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "risklevel_header"
      },
      "source": [
        "## Risk Level Classification"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 4,
      "metadata": {
        "id": "risklevel_cell",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "e7ed0788-4477-4731-c309-1036d965b2fb"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "âœ“ Risk level classification loaded\n",
            "  - Levels: ['CRITICAL', 'HIGH', 'MEDIUM', 'LOW']\n",
            "  - Vernier zone: IMGT positions 75-88\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# RISK LEVEL STRATIFICATION\n",
        "# ============================================================================\n",
        "\n",
        "class RiskLevel(Enum):\n",
        "    \"\"\"Risk classification for glycosylation sites.\"\"\"\n",
        "    CRITICAL = \"CRITICAL\"  # CDR + high occupancy - immediate action required\n",
        "    HIGH = \"HIGH\"          # CDR + medium occupancy OR Framework + high occupancy\n",
        "    MEDIUM = \"MEDIUM\"      # Framework + medium occupancy OR progenitor in CDR\n",
        "    LOW = \"LOW\"            # Low occupancy OR framework progenitor\n",
        "\n",
        "@dataclass\n",
        "class GlycosylationSite:\n",
        "    \"\"\"Complete characterization of a glycosylation site.\"\"\"\n",
        "    position: int                    # Linear sequence position (0-indexed)\n",
        "    imgt_position: Optional[int]     # IMGT position (if available)\n",
        "    motif: str                       # The sequon (e.g., 'NGT', 'NVS')\n",
        "    site_type: str                   # 'actual' or 'progenitor_D_to_N' or 'progenitor_to_ST'\n",
        "    chain: str                       # 'heavy' or 'light'\n",
        "    region: str                      # 'CDR1', 'CDR2', 'CDR3', 'FR1', 'FR2', 'FR3', 'FR4', 'Vernier'\n",
        "    x_residue: str                   # Amino acid at X position\n",
        "    third_residue: str               # S or T at +2 position\n",
        "    x_efficiency: float              # Shakin-Eshleman efficiency score\n",
        "    nxt_nxs_multiplier: float        # NXT vs NXS multiplier\n",
        "    occupancy_score: float           # Combined occupancy probability (0-1)\n",
        "    risk_level: RiskLevel            # CRITICAL/HIGH/MEDIUM/LOW\n",
        "    in_vernier_zone: bool            # IMGT 75-88\n",
        "    mutation_from: Optional[str]     # For progenitors: original AA\n",
        "    mutation_to: Optional[str]       # For progenitors: mutated AA\n",
        "    risk_contribution: float = 0.0   # Points contributed to overall score\n",
        "\n",
        "# IMGT Vernier zone positions (critical for VH/VL packing)\n",
        "VERNIER_ZONE_IMGT = set(range(75, 89))  # IMGT 75-88\n",
        "\n",
        "print(\"âœ“ Risk level classification loaded\")\n",
        "print(f\"  - Levels: {[r.value for r in RiskLevel]}\")\n",
        "print(f\"  - Vernier zone: IMGT positions 75-88\")"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "scanner_header"
      },
      "source": [
        "## Enhanced Scanner Class (v3)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 5,
      "metadata": {
        "id": "scanner_cell",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "94c5250c-98e4-4fd6-d699-83fb40301ccf"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "âœ“ EnhancedGlycosylationScannerV3 class loaded\n",
            "  Scoring calibration:\n",
            "    - Actual CDR site:      30-45 points\n",
            "    - Actual Vernier site:  27-40 points\n",
            "    - Actual Framework:     25-37 points\n",
            "    - Progenitor (Dâ†’N):     3-10 points\n",
            "    - Progenitor (â†’S/T):    2-7 points\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# ENHANCED PROGENITOR GLYCOSYLATION SCANNER v3\n",
        "# ============================================================================\n",
        "\n",
        "class EnhancedGlycosylationScannerV3:\n",
        "    \"\"\"\n",
        "    v3 Scanner with:\n",
        "    - AntPack IMGT numbering\n",
        "    - X-position efficiency scoring (Shakin-Eshleman)\n",
        "    - NXT vs NXS differentiation\n",
        "    - Vernier zone flagging\n",
        "    - Occupancy score calculation\n",
        "    - RiskLevel stratification\n",
        "    \"\"\"\n",
        "\n",
        "    # IMGT CDR boundaries (fallback when AntPack unavailable)\n",
        "    IMGT_REGIONS = {\n",
        "        'FR1': (1, 26),\n",
        "        'CDR1': (27, 38),\n",
        "        'FR2': (39, 55),\n",
        "        'CDR2': (56, 65),\n",
        "        'FR3': (66, 104),\n",
        "        'CDR3': (105, 117),\n",
        "        'FR4': (118, 128),\n",
        "    }\n",
        "\n",
        "    def __init__(self):\n",
        "        \"\"\"Initialize the v3 scanner.\"\"\"\n",
        "        self.annotator_heavy = None\n",
        "        self.annotator_light = None\n",
        "\n",
        "        if ANTPACK_AVAILABLE:\n",
        "            try:\n",
        "                self.annotator_heavy = SingleChainAnnotator(chains=['H'], scheme='imgt')\n",
        "                self.annotator_light = SingleChainAnnotator(chains=['K', 'L'], scheme='imgt')\n",
        "                print(\"âœ“ Scanner v3 initialized with AntPack IMGT numbering\")\n",
        "            except Exception as e:\n",
        "                print(f\"âš ï¸ AntPack initialization failed: {e}\")\n",
        "                print(\"   Falling back to approximate boundaries\")\n",
        "        else:\n",
        "            print(\"âœ“ Scanner v3 initialized with approximate IMGT boundaries\")\n",
        "\n",
        "    def get_imgt_numbering(self, sequence: str, chain_type: str) -> Dict[int, int]:\n",
        "        \"\"\"\n",
        "        Get IMGT numbering for a sequence.\n",
        "\n",
        "        Args:\n",
        "            sequence: Amino acid sequence\n",
        "            chain_type: 'H' for heavy, 'L' for light\n",
        "\n",
        "        Returns:\n",
        "            Dict mapping linear position (0-indexed) to IMGT position\n",
        "        \"\"\"\n",
        "        imgt_map = {}\n",
        "\n",
        "        if ANTPACK_AVAILABLE:\n",
        "            try:\n",
        "                annotator = self.annotator_heavy if chain_type == 'H' else self.annotator_light\n",
        "                numbering, percent_id, chain, err = annotator.analyze_seq(sequence)\n",
        "\n",
        "                if err is None and numbering is not None:\n",
        "                    seq_pos = 0\n",
        "                    for imgt_pos, aa in numbering:\n",
        "                        if aa and aa != '-':\n",
        "                            # Handle insertion codes (e.g., '111A' -> 111)\n",
        "                            try:\n",
        "                                imgt_num = int(''.join(filter(str.isdigit, str(imgt_pos))))\n",
        "                                imgt_map[seq_pos] = imgt_num\n",
        "                            except:\n",
        "                                imgt_map[seq_pos] = seq_pos + 1\n",
        "                            seq_pos += 1\n",
        "            except Exception as e:\n",
        "                pass\n",
        "\n",
        "        # Fallback: approximate mapping\n",
        "        if not imgt_map:\n",
        "            for i in range(len(sequence)):\n",
        "                imgt_map[i] = i + 1\n",
        "\n",
        "        return imgt_map\n",
        "\n",
        "    def get_region(self, imgt_position: int) -> str:\n",
        "        \"\"\"\n",
        "        Determine IMGT region for a position.\n",
        "\n",
        "        Args:\n",
        "            imgt_position: IMGT position number\n",
        "\n",
        "        Returns:\n",
        "            Region name (e.g., 'CDR1', 'FR3')\n",
        "        \"\"\"\n",
        "        for region, (start, end) in self.IMGT_REGIONS.items():\n",
        "            if start <= imgt_position <= end:\n",
        "                return region\n",
        "        return 'Unknown'\n",
        "\n",
        "    def is_in_vernier_zone(self, imgt_position: int) -> bool:\n",
        "        \"\"\"Check if position is in Vernier zone (IMGT 75-88).\"\"\"\n",
        "        return imgt_position in VERNIER_ZONE_IMGT\n",
        "\n",
        "    def calculate_occupancy_score(self, x_residue: str, third_residue: str,\n",
        "                                  region: str, is_vernier: bool,\n",
        "                                  is_progenitor: bool = False) -> float:\n",
        "        \"\"\"\n",
        "        Calculate occupancy probability score.\n",
        "\n",
        "        Combines:\n",
        "        - X-position efficiency (Shakin-Eshleman)\n",
        "        - NXT vs NXS multiplier\n",
        "        - Regional context\n",
        "        - Progenitor probability\n",
        "\n",
        "        Returns:\n",
        "            Occupancy score (0-1)\n",
        "        \"\"\"\n",
        "        # Base efficiency from sequon\n",
        "        base_efficiency = get_sequon_efficiency(x_residue, third_residue)\n",
        "\n",
        "        # Regional accessibility modifier\n",
        "        region_modifier = 1.0\n",
        "        if region.startswith('CDR'):\n",
        "            region_modifier = 1.2  # CDRs are surface-exposed\n",
        "        elif region == 'FR3' or is_vernier:\n",
        "            region_modifier = 0.9  # FR3/Vernier partially buried\n",
        "        else:\n",
        "            region_modifier = 0.8  # Other frameworks\n",
        "\n",
        "        # Progenitor discount (probability of mutation occurring)\n",
        "        # Dâ†’N is ~16.5% likely via SHM, other mutations less likely\n",
        "        progenitor_modifier = 0.25 if is_progenitor else 1.0\n",
        "\n",
        "        occupancy = base_efficiency * region_modifier * progenitor_modifier\n",
        "\n",
        "        return min(occupancy, 1.0)\n",
        "\n",
        "    def classify_risk_level(self, occupancy_score: float, region: str,\n",
        "                           is_vernier: bool, site_type: str) -> RiskLevel:\n",
        "        \"\"\"\n",
        "        Classify site risk level.\n",
        "\n",
        "        Args:\n",
        "            occupancy_score: Calculated occupancy probability\n",
        "            region: IMGT region\n",
        "            is_vernier: Whether in Vernier zone\n",
        "            site_type: 'actual' or 'progenitor_*'\n",
        "\n",
        "        Returns:\n",
        "            RiskLevel enum value\n",
        "        \"\"\"\n",
        "        is_cdr = region.startswith('CDR')\n",
        "        is_progenitor = site_type != 'actual'\n",
        "\n",
        "        # CRITICAL: CDR + high occupancy actual site\n",
        "        if is_cdr and not is_progenitor and occupancy_score >= 0.5:\n",
        "            return RiskLevel.CRITICAL\n",
        "\n",
        "        # HIGH: CDR actual with medium occupancy OR framework actual with high occupancy\n",
        "        if is_cdr and not is_progenitor and occupancy_score >= 0.3:\n",
        "            return RiskLevel.HIGH\n",
        "        if not is_cdr and not is_progenitor and occupancy_score >= 0.5:\n",
        "            return RiskLevel.HIGH\n",
        "\n",
        "        # MEDIUM: Any actual site OR CDR progenitor OR Vernier\n",
        "        if not is_progenitor:\n",
        "            return RiskLevel.MEDIUM\n",
        "        if is_cdr and is_progenitor:\n",
        "            return RiskLevel.MEDIUM\n",
        "        if is_vernier:\n",
        "            return RiskLevel.MEDIUM\n",
        "\n",
        "        # LOW: Framework progenitors\n",
        "        return RiskLevel.LOW\n",
        "\n",
        "    def scan_actual_sites(self, sequence: str, chain_type: str,\n",
        "                         imgt_map: Dict[int, int]) -> List[GlycosylationSite]:\n",
        "        \"\"\"\n",
        "        Find actual N-X-S/T glycosylation sites.\n",
        "\n",
        "        Args:\n",
        "            sequence: Amino acid sequence\n",
        "            chain_type: 'H' or 'L'\n",
        "            imgt_map: Position to IMGT mapping\n",
        "\n",
        "        Returns:\n",
        "            List of GlycosylationSite objects\n",
        "        \"\"\"\n",
        "        sites = []\n",
        "        chain_name = 'heavy' if chain_type == 'H' else 'light'\n",
        "\n",
        "        for i in range(len(sequence) - 2):\n",
        "            if sequence[i] == 'N' and sequence[i+1] != 'P' and sequence[i+2] in ['S', 'T']:\n",
        "                imgt_pos = imgt_map.get(i, i + 1)\n",
        "                region = self.get_region(imgt_pos)\n",
        "                is_vernier = self.is_in_vernier_zone(imgt_pos)\n",
        "\n",
        "                x_residue = sequence[i+1]\n",
        "                third_residue = sequence[i+2]\n",
        "                x_eff = X_POSITION_EFFICIENCY.get(x_residue, 0.5)\n",
        "                nxt_mult = NXT_NXS_MULTIPLIER.get(third_residue, 0.4)\n",
        "\n",
        "                occupancy = self.calculate_occupancy_score(\n",
        "                    x_residue, third_residue, region, is_vernier, is_progenitor=False\n",
        "                )\n",
        "\n",
        "                risk = self.classify_risk_level(occupancy, region, is_vernier, 'actual')\n",
        "\n",
        "                sites.append(GlycosylationSite(\n",
        "                    position=i,\n",
        "                    imgt_position=imgt_pos,\n",
        "                    motif=sequence[i:i+3],\n",
        "                    site_type='actual',\n",
        "                    chain=chain_name,\n",
        "                    region=region,\n",
        "                    x_residue=x_residue,\n",
        "                    third_residue=third_residue,\n",
        "                    x_efficiency=x_eff,\n",
        "                    nxt_nxs_multiplier=nxt_mult,\n",
        "                    occupancy_score=occupancy,\n",
        "                    risk_level=risk,\n",
        "                    in_vernier_zone=is_vernier,\n",
        "                    mutation_from=None,\n",
        "                    mutation_to=None\n",
        "                ))\n",
        "\n",
        "        return sites\n",
        "\n",
        "    def scan_progenitor_sites(self, sequence: str, chain_type: str,\n",
        "                              imgt_map: Dict[int, int]) -> List[GlycosylationSite]:\n",
        "        \"\"\"\n",
        "        Find progenitor sites (one mutation away from N-X-S/T).\n",
        "\n",
        "        Types:\n",
        "        1. D-X-S/T â†’ Dâ†’N creates N-X-S/T\n",
        "        2. N-X-[A/V/I/L] â†’ [A/V/I/L]â†’[S/T] creates N-X-S/T\n",
        "\n",
        "        Args:\n",
        "            sequence: Amino acid sequence\n",
        "            chain_type: 'H' or 'L'\n",
        "            imgt_map: Position to IMGT mapping\n",
        "\n",
        "        Returns:\n",
        "            List of GlycosylationSite objects\n",
        "        \"\"\"\n",
        "        sites = []\n",
        "        chain_name = 'heavy' if chain_type == 'H' else 'light'\n",
        "\n",
        "        # Type 1: D-X-S/T (Dâ†’N creates site)\n",
        "        for i in range(len(sequence) - 2):\n",
        "            if sequence[i] == 'D' and sequence[i+1] != 'P' and sequence[i+2] in ['S', 'T']:\n",
        "                imgt_pos = imgt_map.get(i, i + 1)\n",
        "                region = self.get_region(imgt_pos)\n",
        "                is_vernier = self.is_in_vernier_zone(imgt_pos)\n",
        "\n",
        "                x_residue = sequence[i+1]\n",
        "                third_residue = sequence[i+2]\n",
        "                x_eff = X_POSITION_EFFICIENCY.get(x_residue, 0.5)\n",
        "                nxt_mult = NXT_NXS_MULTIPLIER.get(third_residue, 0.4)\n",
        "\n",
        "                occupancy = self.calculate_occupancy_score(\n",
        "                    x_residue, third_residue, region, is_vernier, is_progenitor=True\n",
        "                )\n",
        "\n",
        "                risk = self.classify_risk_level(occupancy, region, is_vernier, 'progenitor_D_to_N')\n",
        "\n",
        "                sites.append(GlycosylationSite(\n",
        "                    position=i,\n",
        "                    imgt_position=imgt_pos,\n",
        "                    motif=f\"[Dâ†’N]{sequence[i+1]}{sequence[i+2]}\",\n",
        "                    site_type='progenitor_D_to_N',\n",
        "                    chain=chain_name,\n",
        "                    region=region,\n",
        "                    x_residue=x_residue,\n",
        "                    third_residue=third_residue,\n",
        "                    x_efficiency=x_eff,\n",
        "                    nxt_nxs_multiplier=nxt_mult,\n",
        "                    occupancy_score=occupancy,\n",
        "                    risk_level=risk,\n",
        "                    in_vernier_zone=is_vernier,\n",
        "                    mutation_from='D',\n",
        "                    mutation_to='N'\n",
        "                ))\n",
        "\n",
        "        # Type 2: N-X-[A/V/I/L] (â†’S/T creates site)\n",
        "        for i in range(len(sequence) - 2):\n",
        "            if sequence[i] == 'N' and sequence[i+1] != 'P' and sequence[i+2] in ['A', 'V', 'I', 'L']:\n",
        "                imgt_pos = imgt_map.get(i, i + 1)\n",
        "                region = self.get_region(imgt_pos)\n",
        "                is_vernier = self.is_in_vernier_zone(imgt_pos)\n",
        "\n",
        "                x_residue = sequence[i+1]\n",
        "                aa_from = sequence[i+2]\n",
        "\n",
        "                # Assume mutation to T (more efficient than S)\n",
        "                third_residue = 'T'\n",
        "                x_eff = X_POSITION_EFFICIENCY.get(x_residue, 0.5)\n",
        "                nxt_mult = NXT_NXS_MULTIPLIER.get(third_residue, 1.0)\n",
        "\n",
        "                occupancy = self.calculate_occupancy_score(\n",
        "                    x_residue, third_residue, region, is_vernier, is_progenitor=True\n",
        "                )\n",
        "\n",
        "                risk = self.classify_risk_level(occupancy, region, is_vernier, 'progenitor_to_ST')\n",
        "\n",
        "                sites.append(GlycosylationSite(\n",
        "                    position=i,\n",
        "                    imgt_position=imgt_pos,\n",
        "                    motif=f\"N{sequence[i+1]}[{aa_from}â†’S/T]\",\n",
        "                    site_type='progenitor_to_ST',\n",
        "                    chain=chain_name,\n",
        "                    region=region,\n",
        "                    x_residue=x_residue,\n",
        "                    third_residue=third_residue,\n",
        "                    x_efficiency=x_eff,\n",
        "                    nxt_nxs_multiplier=nxt_mult,\n",
        "                    occupancy_score=occupancy,\n",
        "                    risk_level=risk,\n",
        "                    in_vernier_zone=is_vernier,\n",
        "                    mutation_from=aa_from,\n",
        "                    mutation_to='S/T'\n",
        "                ))\n",
        "\n",
        "        return sites\n",
        "\n",
        "    def scan_chain(self, sequence: str, chain_type: str) -> Dict:\n",
        "        \"\"\"\n",
        "        Scan a single chain for glycosylation sites.\n",
        "\n",
        "        Args:\n",
        "            sequence: Amino acid sequence\n",
        "            chain_type: 'H' for heavy, 'L' for light\n",
        "\n",
        "        Returns:\n",
        "            Dict with sites and summary\n",
        "        \"\"\"\n",
        "        imgt_map = self.get_imgt_numbering(sequence, chain_type)\n",
        "\n",
        "        actual_sites = self.scan_actual_sites(sequence, chain_type, imgt_map)\n",
        "        progenitor_sites = self.scan_progenitor_sites(sequence, chain_type, imgt_map)\n",
        "\n",
        "        all_sites = actual_sites + progenitor_sites\n",
        "        all_sites.sort(key=lambda s: s.occupancy_score, reverse=True)\n",
        "\n",
        "        # Count by risk level\n",
        "        risk_counts = {level: 0 for level in RiskLevel}\n",
        "        for site in all_sites:\n",
        "            risk_counts[site.risk_level] += 1\n",
        "\n",
        "        return {\n",
        "            'sites': all_sites,\n",
        "            'actual_count': len(actual_sites),\n",
        "            'progenitor_count': len(progenitor_sites),\n",
        "            'risk_counts': risk_counts,\n",
        "            'cdr_sites': len([s for s in all_sites if s.region.startswith('CDR')]),\n",
        "            'vernier_sites': len([s for s in all_sites if s.in_vernier_zone]),\n",
        "        }\n",
        "\n",
        "    def calculate_risk_score(self, all_sites: List[GlycosylationSite]) -> Tuple[float, List[GlycosylationSite]]:\n",
        "        \"\"\"\n",
        "        Calculate overall risk score (0-100 scale).\n",
        "\n",
        "        CALIBRATED SCORING DESIGN:\n",
        "        =========================\n",
        "        - Actual sites DOMINATE the score (25-45 points each)\n",
        "        - Progenitors add modest risk (2-10 points each)\n",
        "        - Efficiency modulates within these ranges\n",
        "\n",
        "        This ensures antibodies with actual N-X-S/T sites (Cetuximab, Panitumumab)\n",
        "        score 50+ while progenitor-only antibodies score 10-35.\n",
        "\n",
        "        Args:\n",
        "            all_sites: List of all detected sites\n",
        "\n",
        "        Returns:\n",
        "            (risk_score, sites_with_contributions)\n",
        "        \"\"\"\n",
        "        risk_score = 0\n",
        "\n",
        "        for site in all_sites:\n",
        "            is_actual = site.site_type == 'actual'\n",
        "            is_cdr = site.region.startswith('CDR')\n",
        "            is_vernier = site.in_vernier_zone\n",
        "            eff = site.occupancy_score\n",
        "\n",
        "            if is_actual:\n",
        "                # =====================================================\n",
        "                # ACTUAL SITES: The main risk drivers (25-45 pts each)\n",
        "                # =====================================================\n",
        "                if is_cdr:\n",
        "                    # CDR actual: 30-45 points\n",
        "                    # These are the worst - glycans in CDR affect binding\n",
        "                    contribution = 30 + (15 * eff)\n",
        "                elif is_vernier:\n",
        "                    # Vernier actual: 27-40 points\n",
        "                    # Critical for VH/VL packing, near CDRs\n",
        "                    contribution = 27 + (13 * eff)\n",
        "                else:\n",
        "                    # Framework actual: 25-37 points\n",
        "                    # Still significant - affects stability, immunogenicity\n",
        "                    contribution = 25 + (12 * eff)\n",
        "            else:\n",
        "                # =====================================================\n",
        "                # PROGENITOR SITES: Modest risk (2-10 pts each)\n",
        "                # =====================================================\n",
        "                # Dâ†’N progenitors are higher risk (more likely via SHM)\n",
        "                is_d_to_n = site.site_type == 'progenitor_D_to_N'\n",
        "\n",
        "                if is_d_to_n:\n",
        "                    # Dâ†’N mutation is common in SHM (~16.5% of Dâ†’N)\n",
        "                    if is_cdr:\n",
        "                        contribution = 6 + (4 * eff)   # 6-10 pts\n",
        "                    elif is_vernier:\n",
        "                        contribution = 5 + (3 * eff)   # 5-8 pts\n",
        "                    else:\n",
        "                        contribution = 3 + (2 * eff)   # 3-5 pts\n",
        "                else:\n",
        "                    # â†’S/T mutations less common\n",
        "                    if is_cdr:\n",
        "                        contribution = 4 + (3 * eff)   # 4-7 pts\n",
        "                    elif is_vernier:\n",
        "                        contribution = 3 + (2 * eff)   # 3-5 pts\n",
        "                    else:\n",
        "                        contribution = 2 + (1 * eff)   # 2-3 pts\n",
        "\n",
        "            site.risk_contribution = contribution\n",
        "            risk_score += contribution\n",
        "\n",
        "        return min(risk_score, 100), all_sites\n",
        "\n",
        "    def scan_antibody(self, heavy_seq: str, light_seq: str) -> Dict:\n",
        "        \"\"\"\n",
        "        Scan complete antibody (heavy + light chains).\n",
        "\n",
        "        Args:\n",
        "            heavy_seq: Heavy chain variable region sequence\n",
        "            light_seq: Light chain variable region sequence\n",
        "\n",
        "        Returns:\n",
        "            Complete analysis results\n",
        "        \"\"\"\n",
        "        heavy_result = self.scan_chain(heavy_seq, 'H')\n",
        "        light_result = self.scan_chain(light_seq, 'L')\n",
        "\n",
        "        # Aggregate results\n",
        "        all_sites = heavy_result['sites'] + light_result['sites']\n",
        "\n",
        "        # Calculate risk score with contribution tracking\n",
        "        risk_score, all_sites = self.calculate_risk_score(all_sites)\n",
        "\n",
        "        # Sort by contribution (highest first)\n",
        "        all_sites.sort(key=lambda s: s.risk_contribution, reverse=True)\n",
        "\n",
        "        # Determine overall risk level based on score thresholds\n",
        "        # These are calibrated to put actual-site antibodies HIGH+\n",
        "        if risk_score >= 50:\n",
        "            overall_level = 'HIGH'\n",
        "        elif risk_score >= 25:\n",
        "            overall_level = 'MEDIUM'\n",
        "        else:\n",
        "            overall_level = 'LOW'\n",
        "\n",
        "        # Override to CRITICAL if any actual CDR site with high efficiency\n",
        "        if any(s.site_type == 'actual' and s.region.startswith('CDR') and s.occupancy_score >= 0.5 for s in all_sites):\n",
        "            overall_level = 'CRITICAL'\n",
        "\n",
        "        return {\n",
        "            'heavy_chain': heavy_result,\n",
        "            'light_chain': light_result,\n",
        "            'all_sites': all_sites,\n",
        "            'overall_risk_score': risk_score,\n",
        "            'overall_risk_level': overall_level,\n",
        "            'total_actual': heavy_result['actual_count'] + light_result['actual_count'],\n",
        "            'total_progenitor': heavy_result['progenitor_count'] + light_result['progenitor_count'],\n",
        "            'total_cdr_sites': heavy_result['cdr_sites'] + light_result['cdr_sites'],\n",
        "            'total_vernier_sites': heavy_result['vernier_sites'] + light_result['vernier_sites'],\n",
        "        }\n",
        "\n",
        "print(\"âœ“ EnhancedGlycosylationScannerV3 class loaded\")\n",
        "print(\"  Scoring calibration:\")\n",
        "print(\"    - Actual CDR site:      30-45 points\")\n",
        "print(\"    - Actual Vernier site:  27-40 points\")\n",
        "print(\"    - Actual Framework:     25-37 points\")\n",
        "print(\"    - Progenitor (Dâ†’N):     3-10 points\")\n",
        "print(\"    - Progenitor (â†’S/T):    2-7 points\")"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "database_header"
      },
      "source": [
        "## FDA Therapeutic Antibody Database\n",
        "\n",
        "18 FDA-approved therapeutic antibodies for validation"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 14,
      "metadata": {
        "id": "database_cell",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "c4ea3a7b-bb40-4f3d-c753-f7e03ba8563c"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "âœ“ Loaded 18 FDA-approved therapeutic antibodies\n",
            "  Known glycosylated (ground truth positive): 1\n",
            "  Known non-glycosylated (ground truth negative): 17\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# FDA THERAPEUTIC ANTIBODY DATABASE\n",
        "# ============================================================================\n",
        "\n",
        "THERAPEUTIC_ANTIBODIES = {\n",
        "    # ==========================================================================\n",
        "    # ONCOLOGY - HER2 Targeted\n",
        "    # ==========================================================================\n",
        "    'Trastuzumab': {\n",
        "        'heavy': 'EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS',\n",
        "        'light': 'DIQMTQSPSSLSASVGDRVTITCRASQDVNTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSRSGTDFTLTISSLQPEDFATYYCQQHYTTPPTFGQGTKVEIK',\n",
        "        'target': 'HER2',\n",
        "        'known_glyc': False\n",
        "    },\n",
        "\n",
        "    'Pertuzumab': {\n",
        "        'heavy': 'EVQLVESGGGLVQPGGSLRLSCAASGFNIKDYYIHWVRQAPGKGLEWVAVIWYDGSKKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARNLGPSFYFDFWGQGTLVTVSS',\n",
        "        'light': 'DIQMTQSPSSLSASVGDRVTITCRASQDISNYLAWYQQKPGKAPKLLIYYTSKLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQGNTLPYTFGQGTKVEIK',\n",
        "        'target': 'HER2',\n",
        "        'known_glyc': False\n",
        "    },\n",
        "\n",
        "    # ==========================================================================\n",
        "    # ONCOLOGY - EGFR Targeted (KNOWN GLYCOSYLATED)\n",
        "    # ==========================================================================\n",
        "    'Cetuximab': {\n",
        "        'heavy': 'QVQLKQSGPGLVQPSQSLSITCTVSGFSLTNYGVHWVRQSPGKGLEWLGVIWSGGNTDYNTPFTSRLSINKDNSKSQVFFKMNSLQSNDTAIYYCARALTYYDYEFAYWGQGTLVTVSA',\n",
        "        'light': 'DILLTQSPVILSVSPGERVSFSCRASQSIGTNIHWYQQRTNGSPRLLIYYTSILHSGVPSRFSGSGSGTDFTLTISNVQSEDLAEYFCQQNNNWPTTFGAGTKLELK',\n",
        "        'target': 'EGFR',\n",
        "        'known_glyc': True  # Well-documented N88 (IMGT 97) Fab glycosylation\n",
        "    },\n",
        "\n",
        "    'Panitumumab': {\n",
        "        'heavy': 'QVQLQESGPGLVKPSQTLSLTCAISGDSVSSNSAAWNWIRQSPSRGLEWLGRTYYRSKWYNDYAVSVKSRITINPDTSKNQFSLQLNSVTPEDTAVYYCAREVTGDLEDAFDIWGQGTMVTVSS',\n",
        "        'light': 'DIQMTQSPASLSASVGETVTITCRASENIYSYLAWYQQKQGKSPQLLVYNAKTLAEGVPSRFSGSGSGTQFSLKINSLQPEDFGSYYCQHHYGIPPTFGGGTKLEIK',\n",
        "        'target': 'EGFR',\n",
        "        'known_glyc': False  # No Fab N-X-S/T sequon (fully human, unlike chimeric Cetuximab)\n",
        "    },\n",
        "\n",
        "    # ==========================================================================\n",
        "    # ONCOLOGY - PD-1/PD-L1 Checkpoint Inhibitors\n",
        "    # ==========================================================================\n",
        "    'Pembrolizumab': {\n",
        "        'heavy': 'QVQLVQSGVEVKKPGASVKVSCKASGYTFTNYYMYWVRQAPGQGLEWMGGINPSNGGTNFNEKFKNRVTLTTDSSTTTAYMELKSLQFDDTAVYYCARRDYRFDMGFDYWGQGTTVTVSS',\n",
        "        'light': 'EIVLTQSPATLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYDASNRATGIPARFSGSGSGTDFTLTISSLEPEDFAVYYCQQSSNWPRTFGQGTKVEIK',\n",
        "        'target': 'PD-1',\n",
        "        'known_glyc': False\n",
        "    },\n",
        "\n",
        "    'Nivolumab': {\n",
        "        'heavy': 'QVQLVESGGGVVQPGRSLRLDCKASGITFSNSGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATNSGYYSGMDVWGQGTTVTVSS',\n",
        "        'light': 'EIVLTQSPGTLSLSPGERATLSCRASQRVSSSYLAWYQQKPGQAPRLLIYDASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSLPWTFGQGTKVEIK',\n",
        "        'target': 'PD-1',\n",
        "        'known_glyc': False\n",
        "    },\n",
        "\n",
        "    'Atezolizumab': {\n",
        "        'heavy': 'EVQLVESGGGLVQPGGSLRLSCAASGFTFSDSWIHWVRQAPGKGLEWVAWISPYGGSTYYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARRHWPGGFDYWGQGTLVTVSS',\n",
        "        'light': 'DIQMTQSPSSLSASVGDRVTITCRASQDVSTAVAWYQQKPGKAPKLLIYSASFLYSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYLYHPATFGQGTKVEIK',\n",
        "        'target': 'PD-L1',\n",
        "        'known_glyc': False\n",
        "    },\n",
        "\n",
        "    'Durvalumab': {\n",
        "        'heavy': 'EVQLVESGGGLVQPGGSLRLSCAASGFTFSRYWMSWVRQAPGKGLEWVANIKQDGSEKYYVDSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCTRHDGDYWGQGTLVTVSS',\n",
        "        'light': 'EIVLTQSPGTLSLSPGERATLSCRASQSVSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK',\n",
        "        'target': 'PD-L1',\n",
        "        'known_glyc': False\n",
        "    },\n",
        "\n",
        "    'Ipilimumab': {\n",
        "        'heavy': 'QVQLVESGGGVVQPGRSLRLDCKASGITFSNSGMHWVRQAPGKGLEWVAVIWYDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCATASYRYYFGMDVWGQGTTVTVSS',\n",
        "        'light': 'EIVLTQSPGTLSLSPGERATLSCRASQSVGSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK',\n",
        "        'target': 'CTLA-4',\n",
        "        'known_glyc': False\n",
        "    },\n",
        "\n",
        "    # ==========================================================================\n",
        "    # ONCOLOGY - VEGF/Angiogenesis\n",
        "    # ==========================================================================\n",
        "    'Bevacizumab': {\n",
        "        'heavy': 'EVQLVESGGGLVQPGGSLRLSCAASGYTFTNYGMNWVRQAPGKGLEWVGWINTYTGEPTYAADFKRRFTFSLDTSKSTAYLQMNSLRAEDTAVYYCAKYPHYYGSSHWYFDVWGQGTLVTVSS',\n",
        "        'light': 'DIQMTQSPSSLSASVGDRVTITCSASQDISNYLNWYQQKPGKAPKVLIYFTSSLHSGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSTVPWTFGQGTKVEIK',\n",
        "        'target': 'VEGF-A',\n",
        "        'known_glyc': False\n",
        "    },\n",
        "\n",
        "    # ==========================================================================\n",
        "    # ONCOLOGY - Hematological\n",
        "    # ==========================================================================\n",
        "    'Rituximab': {\n",
        "        'heavy': 'QVQLQQPGAELVKPGASVKMSCKASGYTFTSYNMHWVKQTPGRGLEWIGAIYPGNGDTSYNQKFKGKATLTADKSSSTAYMQLSSLTSEDSAVYYCARSTYYGGDWYFNVWGAGTTVTVSA',\n",
        "        'light': 'QIVLSQSPAILSASPGEKVTMTCRASSSVSYMNWYQQKPGTSPKRWIYDTSKVASGVPYRFSGSGSGTSYSLTISSMEAEDAATYYCHQWSSNPFTFGSGTKLEIK',\n",
        "        'target': 'CD20',\n",
        "        'known_glyc': False\n",
        "    },\n",
        "\n",
        "    # ==========================================================================\n",
        "    # AUTOIMMUNE - TNF Inhibitors\n",
        "    # ==========================================================================\n",
        "    'Adalimumab': {\n",
        "        'heavy': 'EVQLVESGGGLVQPGRSLRLSCAASGFTFDDYAMHWVRQAPGKGLEWVSAITWNSGHIDYADSVEGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCAKVSYLSTASSLDYWGQGTLVTVSS',\n",
        "        'light': 'DIQMTQSPSSLSASVGDRVTITCRASQGIRNYLAWYQQKPGKAPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDIATYYCQRYNRAPYTFGQGTKVEIK',\n",
        "        'target': 'TNF-alpha',\n",
        "        'known_glyc': False\n",
        "    },\n",
        "\n",
        "    'Infliximab': {\n",
        "        'heavy': 'EVQLVESGGGLVQPGRSLRLSCAASGFTFSDYGMHWVRQAPGKGLEWVAYISSGSSTIYYADTVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDKGYSSWYFDVWGQGTLVTVSS',\n",
        "        'light': 'DIQMTQSPSSLSASVGDRVTITCRASQGISNYLAWYQQKPGKVPKLLIYAASTLQSGVPSRFSGSGSGTDFTLTISSLQPEDVATYYCQKYNSAPLTFGGGTKVEIK',\n",
        "        'target': 'TNF-alpha',\n",
        "        'known_glyc': False\n",
        "    },\n",
        "\n",
        "    # ==========================================================================\n",
        "    # AUTOIMMUNE - Interleukin Inhibitors\n",
        "    # ==========================================================================\n",
        "    'Ustekinumab': {\n",
        "        'heavy': 'EVQLVQSGAEVKKPGSSVKVSCKASGGTFSSYAISWVRQAPGQGLEWMGGIIPIFDTANYAQKFQGRVTITADKSTSTAYMELSSLRSEDTAVYYCARGGVFDYWGQGTLVTVSS',\n",
        "        'light': 'DIQMTQSPSSLSASVGDRVTITCRASQGISSALAWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQFNSYPLTFGQGTKVEIK',\n",
        "        'target': 'IL-12/IL-23',\n",
        "        'known_glyc': False\n",
        "    },\n",
        "\n",
        "    'Tocilizumab': {\n",
        "        'heavy': 'QVQLQESGPGLVKPSETLSLTCTVSGFSLTDYGVNWVRQPPGKGLEWIGMIWGDGSTDYNSALKSRVTISKDTSKNQFSLKLSSVTAADTAVYYCARDGGITVFGTPWWKDDYWGQGTLVTVSS',\n",
        "        'light': 'DIQMTQSPSSLSASVGDRVTITCQASQDISNYLNWYQQKPGKAPKLLIYDASNLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCQQYDNLPFTFGPGTKVDIK',\n",
        "        'target': 'IL-6R',\n",
        "        'known_glyc': False\n",
        "    },\n",
        "\n",
        "    # ==========================================================================\n",
        "    # BONE - RANKL Inhibitors\n",
        "    # ==========================================================================\n",
        "    'Denosumab': {\n",
        "        'heavy': 'EVQLLESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDPGEGLGPLWFAYWGQGTLVTVSS',\n",
        "        'light': 'EIVLTQSPGTLSLSPGERATLSCRASQSVSSSYLAWYQQKPGQAPRLLIYGASSRATGIPDRFSGSGSGTDFTLTISRLEPEDFAVYYCQQYGSSPWTFGQGTKVEIK',\n",
        "        'target': 'RANKL',\n",
        "        'known_glyc': False\n",
        "    },\n",
        "\n",
        "    # ==========================================================================\n",
        "    # TRANSPLANTATION\n",
        "    # ==========================================================================\n",
        "    'Alemtuzumab': {\n",
        "        'heavy': 'QVQLQESGPGLVKPSQTLSLTCTVSGFSLTDYGVNWIRQPPGKGLEWMGMIWGDGNTDYNSALKSRLTISKDTSKNQVSLKLSSVTAADTAVYYCARSGFITTVVDDYWGQGTLVTVSS',\n",
        "        'light': 'DIQMTQSPSSLSASVGDRVTITCKASQNIDKYLNWYQQKPGKAPKLLIYNTNNLQTGVPSRFSGSGSGTDFTFTISSLQPEDIATYYCLQHISRPRTFGQGTKVEIK',\n",
        "        'target': 'CD52',\n",
        "        'known_glyc': False\n",
        "    },\n",
        "\n",
        "    # ==========================================================================\n",
        "    # INFECTIOUS DISEASE\n",
        "    # ==========================================================================\n",
        "    'Palivizumab': {\n",
        "        'heavy': 'QVTLRESGPALVKPTQTLTLTCTFSGFSLSTSGMGVSWIRQPPGKALEWLADIWWDDKKDYNPSLKSRLTISKDTSKNQVVLKVTNMDPADTATYYCARSMITNWYFDVWGAGTTVTVSS',\n",
        "        'light': 'DIQMTQSPSSLSASVGDRVTITCQASQDIVNYLNWYQQKPGKAPKLLIYVASHLETGVPSRFSGSGSGTDFTFTISSLQPEDIATYFCQQYDNLPLTFGAGTKVEIK',\n",
        "        'target': 'RSV',\n",
        "        'known_glyc': False\n",
        "    },\n",
        "}\n",
        "\n",
        "print(f\"âœ“ Loaded {len(THERAPEUTIC_ANTIBODIES)} FDA-approved therapeutic antibodies\")\n",
        "print(f\"  Known glycosylated (ground truth positive): {sum(1 for ab in THERAPEUTIC_ANTIBODIES.values() if ab['known_glyc'])}\")\n",
        "print(f\"  Known non-glycosylated (ground truth negative): {sum(1 for ab in THERAPEUTIC_ANTIBODIES.values() if not ab['known_glyc'])}\")"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "run_header"
      },
      "source": [
        "## Run Validation Analysis"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 15,
      "metadata": {
        "id": "run_cell",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "9143dc98-c5fe-4223-f30c-df6c20967f2b"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "================================================================================\n",
            "RUNNING v3 ENHANCED SCANNER ON 18 FDA-APPROVED ANTIBODIES\n",
            "================================================================================\n",
            "\n",
            "âœ“ Scanner v3 initialized with AntPack IMGT numbering\n",
            "\n",
            "   Trastuzumab     (HER2        ): Risk=LOW     , Score= 18.0, Actual=0, Progenitor=5\n",
            "   Pertuzumab      (HER2        ): Risk=MEDIUM  , Score= 29.2, Actual=0, Progenitor=8\n",
            "â˜…â˜… Cetuximab       (EGFR        ): Risk=HIGH    , Score= 67.7, Actual=2, Progenitor=3\n",
            "   Panitumumab     (EGFR        ): Risk=LOW     , Score= 21.1, Actual=0, Progenitor=5\n",
            "   Pembrolizumab   (PD-1        ): Risk=LOW     , Score= 16.8, Actual=0, Progenitor=6\n",
            "   Nivolumab       (PD-1        ): Risk=LOW     , Score= 19.4, Actual=0, Progenitor=6\n",
            "   Atezolizumab    (PD-L1       ): Risk=LOW     , Score= 19.6, Actual=0, Progenitor=5\n",
            "   Durvalumab      (PD-L1       ): Risk=LOW     , Score= 13.2, Actual=0, Progenitor=4\n",
            "   Ipilimumab      (CTLA-4      ): Risk=LOW     , Score= 16.3, Actual=0, Progenitor=5\n",
            "   Bevacizumab     (VEGF-A      ): Risk=LOW     , Score= 24.8, Actual=0, Progenitor=6\n",
            "   Rituximab       (CD20        ): Risk=LOW     , Score= 12.6, Actual=0, Progenitor=3\n",
            "   Adalimumab      (TNF-alpha   ): Risk=LOW     , Score= 16.6, Actual=0, Progenitor=5\n",
            "   Infliximab      (TNF-alpha   ): Risk=LOW     , Score= 16.7, Actual=0, Progenitor=5\n",
            "   Ustekinumab     (IL-12/IL-23 ): Risk=LOW     , Score= 13.9, Actual=0, Progenitor=4\n",
            "   Tocilizumab     (IL-6R       ): Risk=MEDIUM  , Score= 32.5, Actual=0, Progenitor=8\n",
            "   Denosumab       (RANKL       ): Risk=LOW     , Score= 13.1, Actual=0, Progenitor=4\n",
            "   Alemtuzumab     (CD52        ): Risk=LOW     , Score= 20.8, Actual=0, Progenitor=6\n",
            "   Palivizumab     (RSV         ): Risk=LOW     , Score= 14.1, Actual=0, Progenitor=4\n",
            "\n",
            "â˜…â˜… = Known glycosylated (ground truth positive)\n",
            "\n",
            "================================================================================\n",
            "âœ“ ALL 18 ANTIBODIES SCANNED SUCCESSFULLY\n",
            "================================================================================\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# RUN v3 SCANNER ON ALL 18 ANTIBODIES\n",
        "# ============================================================================\n",
        "\n",
        "print(\"=\"*80)\n",
        "print(\"RUNNING v3 ENHANCED SCANNER ON 18 FDA-APPROVED ANTIBODIES\")\n",
        "print(\"=\"*80)\n",
        "print()\n",
        "\n",
        "# Initialize scanner\n",
        "scanner = EnhancedGlycosylationScannerV3()\n",
        "print()\n",
        "\n",
        "# Run analysis\n",
        "all_results = {}\n",
        "for ab_name, ab_data in THERAPEUTIC_ANTIBODIES.items():\n",
        "    result = scanner.scan_antibody(ab_data['heavy'], ab_data['light'])\n",
        "    result['known_glycosylation'] = ab_data['known_glyc']\n",
        "    result['target'] = ab_data['target']\n",
        "    all_results[ab_name] = result\n",
        "\n",
        "    flag = 'â˜…â˜…' if ab_data['known_glyc'] else '  '\n",
        "    print(f\"{flag} {ab_name:15s} ({ab_data['target']:12s}): \"\n",
        "          f\"Risk={result['overall_risk_level']:8s}, \"\n",
        "          f\"Score={result['overall_risk_score']:5.1f}, \"\n",
        "          f\"Actual={result['total_actual']}, \"\n",
        "          f\"Progenitor={result['total_progenitor']}\")\n",
        "\n",
        "print()\n",
        "print(\"â˜…â˜… = Known glycosylated (ground truth positive)\")\n",
        "print()\n",
        "print(\"=\"*80)\n",
        "print(f\"âœ“ ALL {len(THERAPEUTIC_ANTIBODIES)} ANTIBODIES SCANNED SUCCESSFULLY\")\n",
        "print(\"=\"*80)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "validation_header"
      },
      "source": [
        "## Validation Metrics"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 17,
      "metadata": {
        "id": "validation_cell",
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 1000
        },
        "outputId": "b8f3946d-4f24-408e-a42f-2ae150c79684"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "================================================================================\n",
            "VALIDATION ANALYSIS\n",
            "================================================================================\n",
            "\n",
            "Analyzing 18 antibodies...\n",
            "Known glycosylated: 1\n",
            "Known non-glycosylated: 17\n",
            "\n",
            "--------------------------------------------------------------------------------\n",
            "Performance at different thresholds:\n",
            "Threshold    Sens       Spec       Prec       Acc        TP    FP    TN    FN   \n",
            "--------------------------------------------------------------------------------\n",
            "25           1.000      0.882      0.333      0.889      1     2     15    0    \n",
            "30           1.000      0.941      0.500      0.944      1     1     16    0    \n",
            "35           1.000      1.000      1.000      1.000      1     0     17    0    \n",
            "40           1.000      1.000      1.000      1.000      1     0     17    0    \n",
            "45           1.000      1.000      1.000      1.000      1     0     17    0    \n",
            "50           1.000      1.000      1.000      1.000      1     0     17    0    \n",
            "55           1.000      1.000      1.000      1.000      1     0     17    0    \n",
            "60           1.000      1.000      1.000      1.000      1     0     17    0    \n",
            "\n",
            "================================================================================\n",
            "GENERATING VALIDATION PLOTS...\n",
            "================================================================================\n"
          ]
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": [
              "<Figure size 1400x1200 with 5 Axes>"
            ],
            "image/png": "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\n"
          },
          "metadata": {}
        },
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "================================================================================\n",
            "VALIDATION METRICS\n",
            "================================================================================\n",
            "ROC AUC: 1.000\n",
            "Average Precision: 0.237\n",
            "\n",
            "Confusion Matrix (threshold=50):\n",
            "  True Positives:   1 (Cetuximab correctly flagged)\n",
            "  True Negatives:   17 (Non-glycosylated correctly cleared)\n",
            "  False Positives:  0 (Non-glycosylated incorrectly flagged)\n",
            "  False Negatives:  0 (Glycosylated missed)\n",
            "\n",
            "  Sensitivity (Recall): 1.000\n",
            "  Specificity:          1.000\n",
            "  Precision:            1.000\n",
            "  Accuracy:             1.000\n",
            "================================================================================\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# VALIDATION ANALYSIS\n",
        "# ============================================================================\n",
        "\n",
        "class ValidationAnalyzer:\n",
        "    \"\"\"\n",
        "    Statistical validation against ground truth.\n",
        "    \"\"\"\n",
        "\n",
        "    def __init__(self, results: Dict):\n",
        "        self.results = results\n",
        "        self.ground_truth = {name: data['known_glycosylation']\n",
        "                            for name, data in results.items()}\n",
        "\n",
        "    def calculate_roc_auc(self) -> Tuple[np.ndarray, np.ndarray, float]:\n",
        "        \"\"\"Calculate ROC curve and AUC.\"\"\"\n",
        "        y_true = []\n",
        "        y_scores = []\n",
        "\n",
        "        for ab_name, has_glyc in self.ground_truth.items():\n",
        "            if ab_name in self.results:\n",
        "                y_true.append(1 if has_glyc else 0)\n",
        "                y_scores.append(self.results[ab_name]['overall_risk_score'])\n",
        "\n",
        "        fpr, tpr, _ = roc_curve(y_true, y_scores)\n",
        "        auc_score = auc(fpr, tpr)\n",
        "\n",
        "        return fpr, tpr, auc_score\n",
        "\n",
        "    def calculate_precision_recall(self) -> Tuple[np.ndarray, np.ndarray, float]:\n",
        "        \"\"\"Calculate precision-recall curve.\"\"\"\n",
        "        y_true = []\n",
        "        y_scores = []\n",
        "\n",
        "        for ab_name, has_glyc in self.ground_truth.items():\n",
        "            if ab_name in self.results:\n",
        "                y_true.append(1 if has_glyc else 0)\n",
        "                y_scores.append(self.results[ab_name]['overall_risk_score'])\n",
        "\n",
        "        precision, recall, _ = precision_recall_curve(y_true, y_scores)\n",
        "        avg_precision = np.mean(precision)\n",
        "\n",
        "        return precision, recall, avg_precision\n",
        "\n",
        "    def calculate_confusion_matrix(self, threshold: float = 50.0) -> Dict:\n",
        "        \"\"\"Calculate confusion matrix at given threshold.\"\"\"\n",
        "        tp = fp = tn = fn = 0\n",
        "\n",
        "        for ab_name, has_glyc in self.ground_truth.items():\n",
        "            if ab_name in self.results:\n",
        "                risk_score = self.results[ab_name]['overall_risk_score']\n",
        "                predicted_positive = risk_score >= threshold\n",
        "\n",
        "                if has_glyc and predicted_positive:\n",
        "                    tp += 1\n",
        "                elif has_glyc and not predicted_positive:\n",
        "                    fn += 1\n",
        "                elif not has_glyc and predicted_positive:\n",
        "                    fp += 1\n",
        "                else:\n",
        "                    tn += 1\n",
        "\n",
        "        total = tp + fp + tn + fn\n",
        "        return {\n",
        "            'TP': tp, 'FP': fp, 'TN': tn, 'FN': fn,\n",
        "            'sensitivity': tp / (tp + fn) if (tp + fn) > 0 else 0,\n",
        "            'specificity': tn / (tn + fp) if (tn + fp) > 0 else 0,\n",
        "            'precision': tp / (tp + fp) if (tp + fp) > 0 else 0,\n",
        "            'accuracy': (tp + tn) / total if total > 0 else 0\n",
        "        }\n",
        "\n",
        "    def plot_validation_metrics(self, save_path: Optional[str] = None):\n",
        "        \"\"\"Create comprehensive validation plots.\"\"\"\n",
        "        fig, axes = plt.subplots(2, 2, figsize=(14, 12))\n",
        "\n",
        "        # ROC Curve\n",
        "        fpr, tpr, auc_score = self.calculate_roc_auc()\n",
        "        axes[0, 0].plot(fpr, tpr, linewidth=2, color='#2E86AB', label=f'AUC = {auc_score:.3f}')\n",
        "        axes[0, 0].plot([0, 1], [0, 1], 'k--', linewidth=1, alpha=0.5)\n",
        "        axes[0, 0].fill_between(fpr, tpr, alpha=0.2, color='#2E86AB')\n",
        "        axes[0, 0].set_xlabel('False Positive Rate', fontsize=12)\n",
        "        axes[0, 0].set_ylabel('True Positive Rate', fontsize=12)\n",
        "        axes[0, 0].set_title('ROC Curve - v3 Glycosylation Risk Prediction', fontsize=13, fontweight='bold')\n",
        "        axes[0, 0].legend(fontsize=11, loc='lower right')\n",
        "        axes[0, 0].grid(alpha=0.3)\n",
        "        axes[0, 0].set_xlim([-0.02, 1.02])\n",
        "        axes[0, 0].set_ylim([-0.02, 1.02])\n",
        "\n",
        "        # Precision-Recall Curve\n",
        "        precision, recall, avg_prec = self.calculate_precision_recall()\n",
        "        axes[0, 1].plot(recall, precision, linewidth=2, color='#A23B72', label=f'Avg Precision = {avg_prec:.3f}')\n",
        "        axes[0, 1].fill_between(recall, precision, alpha=0.2, color='#A23B72')\n",
        "        axes[0, 1].set_xlabel('Recall', fontsize=12)\n",
        "        axes[0, 1].set_ylabel('Precision', fontsize=12)\n",
        "        axes[0, 1].set_title('Precision-Recall Curve', fontsize=13, fontweight='bold')\n",
        "        axes[0, 1].legend(fontsize=11, loc='upper right')\n",
        "        axes[0, 1].grid(alpha=0.3)\n",
        "\n",
        "        # Risk Score Distribution with proper separation\n",
        "        glyc_scores = [self.results[ab]['overall_risk_score']\n",
        "                       for ab, has_glyc in self.ground_truth.items()\n",
        "                       if ab in self.results and has_glyc]\n",
        "        non_glyc_scores = [self.results[ab]['overall_risk_score']\n",
        "                           for ab, has_glyc in self.ground_truth.items()\n",
        "                           if ab in self.results and not has_glyc]\n",
        "\n",
        "        # Use fixed bins for better visualization\n",
        "        bins = np.arange(0, 105, 5)\n",
        "        axes[1, 0].hist(non_glyc_scores, bins=bins, alpha=0.7, label=f'Non-Glycosylated (n={len(non_glyc_scores)})',\n",
        "                        color='#3498db', edgecolor='white', linewidth=0.5)\n",
        "        axes[1, 0].hist(glyc_scores, bins=bins, alpha=0.85, label=f'Known Glycosylated (n={len(glyc_scores)})',\n",
        "                        color='#e74c3c', edgecolor='white', linewidth=0.5)\n",
        "        axes[1, 0].axvline(x=50, color='#f39c12', linestyle='--', linewidth=2.5, label='Threshold=50')\n",
        "        axes[1, 0].set_xlabel('Risk Score', fontsize=12)\n",
        "        axes[1, 0].set_ylabel('Count', fontsize=12)\n",
        "        axes[1, 0].set_title('Risk Score Distribution', fontsize=13, fontweight='bold')\n",
        "        axes[1, 0].legend(fontsize=10, loc='upper right')\n",
        "        axes[1, 0].grid(alpha=0.3, axis='y')\n",
        "        axes[1, 0].set_xlim([0, 100])\n",
        "\n",
        "        # Confusion Matrix\n",
        "        cm = self.calculate_confusion_matrix(threshold=50.0)\n",
        "        cm_matrix = np.array([[cm['TN'], cm['FP']], [cm['FN'], cm['TP']]])\n",
        "        sns.heatmap(cm_matrix, annot=True, fmt='d', cmap='Blues', ax=axes[1, 1],\n",
        "                    xticklabels=['Predicted Neg', 'Predicted Pos'],\n",
        "                    yticklabels=['Actually Neg', 'Actually Pos'],\n",
        "                    annot_kws={'size': 18, 'weight': 'bold'},\n",
        "                    cbar_kws={'shrink': 0.8})\n",
        "        axes[1, 1].set_title('Confusion Matrix (threshold=50)', fontsize=13, fontweight='bold')\n",
        "\n",
        "        plt.tight_layout()\n",
        "\n",
        "        if save_path:\n",
        "            plt.savefig(save_path, dpi=300, bbox_inches='tight')\n",
        "\n",
        "        plt.show()\n",
        "\n",
        "        # Print metrics\n",
        "        print(\"\\n\" + \"=\"*80)\n",
        "        print(\"VALIDATION METRICS\")\n",
        "        print(\"=\"*80)\n",
        "        print(f\"ROC AUC: {auc_score:.3f}\")\n",
        "        print(f\"Average Precision: {avg_prec:.3f}\")\n",
        "        print(f\"\\nConfusion Matrix (threshold=50):\")\n",
        "        print(f\"  True Positives:   {cm['TP']} (Cetuximab correctly flagged)\")\n",
        "        print(f\"  True Negatives:   {cm['TN']} (Non-glycosylated correctly cleared)\")\n",
        "        print(f\"  False Positives:  {cm['FP']} (Non-glycosylated incorrectly flagged)\")\n",
        "        print(f\"  False Negatives:  {cm['FN']} (Glycosylated missed)\")\n",
        "        print(f\"\\n  Sensitivity (Recall): {cm['sensitivity']:.3f}\")\n",
        "        print(f\"  Specificity:          {cm['specificity']:.3f}\")\n",
        "        print(f\"  Precision:            {cm['precision']:.3f}\" if cm['precision'] > 0 else \"  Precision:            N/A (no positives predicted)\")\n",
        "        print(f\"  Accuracy:             {cm['accuracy']:.3f}\")\n",
        "        print(\"=\"*80)\n",
        "\n",
        "# Run validation\n",
        "print(\"\\n\" + \"=\"*80)\n",
        "print(\"VALIDATION ANALYSIS\")\n",
        "print(\"=\"*80)\n",
        "\n",
        "validator = ValidationAnalyzer(all_results)\n",
        "\n",
        "print(f\"\\nAnalyzing {len(all_results)} antibodies...\")\n",
        "print(f\"Known glycosylated: {sum(1 for r in all_results.values() if r['known_glycosylation'])}\")\n",
        "print(f\"Known non-glycosylated: {sum(1 for r in all_results.values() if not r['known_glycosylation'])}\")\n",
        "\n",
        "# Test multiple thresholds\n",
        "print(\"\\n\" + \"-\"*80)\n",
        "print(\"Performance at different thresholds:\")\n",
        "print(f\"{'Threshold':<12} {'Sens':<10} {'Spec':<10} {'Prec':<10} {'Acc':<10} {'TP':<5} {'FP':<5} {'TN':<5} {'FN':<5}\")\n",
        "print(\"-\"*80)\n",
        "\n",
        "for threshold in [25, 30, 35, 40, 45, 50, 55, 60]:\n",
        "    cm = validator.calculate_confusion_matrix(threshold=threshold)\n",
        "    prec_str = f\"{cm['precision']:.3f}\" if cm['precision'] > 0 or cm['TP'] > 0 else \"N/A\"\n",
        "    print(f\"{threshold:<12} {cm['sensitivity']:<10.3f} {cm['specificity']:<10.3f} {prec_str:<10} {cm['accuracy']:<10.3f} {cm['TP']:<5} {cm['FP']:<5} {cm['TN']:<5} {cm['FN']:<5}\")\n",
        "\n",
        "# Plot validation metrics\n",
        "print(\"\\n\" + \"=\"*80)\n",
        "print(\"GENERATING VALIDATION PLOTS...\")\n",
        "print(\"=\"*80)\n",
        "\n",
        "validator.plot_validation_metrics()"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "summary_header"
      },
      "source": [
        "## Results Summary"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 18,
      "metadata": {
        "id": "summary_cell",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "ef450765-44e8-4fbc-9386-029d80273534"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "\n",
            "âœ“ Results exported to 'fda_glycosylation_validation_v3.csv'\n",
            "\n",
            "========================================================================================================================\n",
            "v3 ENHANCED GLYCOSYLATION RISK ANALYSIS - SUMMARY\n",
            "========================================================================================================================\n",
            "     Antibody      Target Known_Glyc Risk_Level  Risk_Score  Actual_Sites  Progenitor  CDR_Sites Top_Actual_Motif Top_Actual_IMGT  Top_Contrib\n",
            "    Cetuximab        EGFR      â˜… YES       HIGH        67.7             2           3          0              NDT              88         29.9\n",
            "  Tocilizumab       IL-6R         NO     MEDIUM        32.5             0           8          4                -               -          6.3\n",
            "   Pertuzumab        HER2         NO     MEDIUM        29.2             0           8          2                -               -          6.3\n",
            "  Bevacizumab      VEGF-A         NO        LOW        24.8             0           6          3                -               -          6.3\n",
            "  Panitumumab        EGFR         NO        LOW        21.1             0           5          2                -               -          5.2\n",
            "  Alemtuzumab        CD52         NO        LOW        20.8             0           6          2                -               -          4.8\n",
            " Atezolizumab       PD-L1         NO        LOW        19.6             0           5          1                -               -          6.4\n",
            "    Nivolumab        PD-1         NO        LOW        19.4             0           6          0                -               -          3.4\n",
            "  Trastuzumab        HER2         NO        LOW        18.0             0           5          1                -               -          4.8\n",
            "Pembrolizumab        PD-1         NO        LOW        16.8             0           6          0                -               -          3.2\n",
            "   Infliximab   TNF-alpha         NO        LOW        16.7             0           5          1                -               -          4.5\n",
            "   Adalimumab   TNF-alpha         NO        LOW        16.6             0           5          1                -               -          4.5\n",
            "   Ipilimumab      CTLA-4         NO        LOW        16.3             0           5          0                -               -          3.4\n",
            "  Palivizumab         RSV         NO        LOW        14.1             0           4          1                -               -          4.5\n",
            "  Ustekinumab IL-12/IL-23         NO        LOW        13.9             0           4          1                -               -          4.5\n",
            "   Durvalumab       PD-L1         NO        LOW        13.2             0           4          0                -               -          3.4\n",
            "    Denosumab       RANKL         NO        LOW        13.1             0           4          0                -               -          3.4\n",
            "    Rituximab        CD20         NO        LOW        12.6             0           3          1                -               -          6.4\n",
            "\n",
            "========================================================================================================================\n",
            "KEY FINDINGS\n",
            "========================================================================================================================\n",
            "\n",
            "âœ“ Known glycosylated antibodies (Cetuximab, Panitumumab):\n",
            "   Mean risk score: 67.7\n",
            "   Score range: 67.7 - 67.7\n",
            "\n",
            "âœ“ Non-glycosylated antibodies (n=16):\n",
            "   Mean risk score: 18.7\n",
            "   Score range: 12.6 - 32.5\n",
            "\n",
            "âœ“ Score separation: 35.2 points\n",
            "   â†’ Clear separation between classes (no overlap)\n",
            "\n",
            "========================================================================================================================\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# COMPREHENSIVE SUMMARY TABLE\n",
        "# ============================================================================\n",
        "\n",
        "summary_data = []\n",
        "for ab_name, result in all_results.items():\n",
        "    # Get top risk site\n",
        "    all_sites = result['all_sites']\n",
        "    top_site = all_sites[0] if all_sites else None\n",
        "\n",
        "    # Get top actual site specifically\n",
        "    actual_sites = [s for s in all_sites if s.site_type == 'actual']\n",
        "    top_actual = actual_sites[0] if actual_sites else None\n",
        "\n",
        "    summary_data.append({\n",
        "        'Antibody': ab_name,\n",
        "        'Target': result['target'],\n",
        "        'Known_Glyc': 'â˜… YES' if result['known_glycosylation'] else 'NO',\n",
        "        'Risk_Level': result['overall_risk_level'],\n",
        "        'Risk_Score': round(result['overall_risk_score'], 1),\n",
        "        'Actual_Sites': result['total_actual'],\n",
        "        'Progenitor': result['total_progenitor'],\n",
        "        'CDR_Sites': result['total_cdr_sites'],\n",
        "        'Top_Actual_Motif': top_actual.motif if top_actual else '-',\n",
        "        'Top_Actual_IMGT': top_actual.imgt_position if top_actual else '-',\n",
        "        'Top_Contrib': round(top_site.risk_contribution, 1) if top_site else 0,\n",
        "    })\n",
        "\n",
        "df = pd.DataFrame(summary_data)\n",
        "df = df.sort_values('Risk_Score', ascending=False)\n",
        "\n",
        "# Save to CSV\n",
        "df.to_csv('fda_glycosylation_validation_v3.csv', index=False)\n",
        "print(\"\\nâœ“ Results exported to 'fda_glycosylation_validation_v3.csv'\")\n",
        "\n",
        "# Display summary\n",
        "print(\"\\n\" + \"=\"*120)\n",
        "print(\"v3 ENHANCED GLYCOSYLATION RISK ANALYSIS - SUMMARY\")\n",
        "print(\"=\"*120)\n",
        "print(df.to_string(index=False))\n",
        "\n",
        "# Key findings\n",
        "print(\"\\n\" + \"=\"*120)\n",
        "print(\"KEY FINDINGS\")\n",
        "print(\"=\"*120)\n",
        "\n",
        "glyc_abs = df[df['Known_Glyc'] == 'â˜… YES']\n",
        "non_glyc_abs = df[df['Known_Glyc'] == 'NO']\n",
        "\n",
        "print(f\"\\nâœ“ Known glycosylated antibodies (Cetuximab, Panitumumab):\")\n",
        "print(f\"   Mean risk score: {glyc_abs['Risk_Score'].mean():.1f}\")\n",
        "print(f\"   Score range: {glyc_abs['Risk_Score'].min():.1f} - {glyc_abs['Risk_Score'].max():.1f}\")\n",
        "\n",
        "print(f\"\\nâœ“ Non-glycosylated antibodies (n=16):\")\n",
        "print(f\"   Mean risk score: {non_glyc_abs['Risk_Score'].mean():.1f}\")\n",
        "print(f\"   Score range: {non_glyc_abs['Risk_Score'].min():.1f} - {non_glyc_abs['Risk_Score'].max():.1f}\")\n",
        "\n",
        "# Score separation\n",
        "min_glyc = glyc_abs['Risk_Score'].min()\n",
        "max_non_glyc = non_glyc_abs['Risk_Score'].max()\n",
        "separation = min_glyc - max_non_glyc\n",
        "\n",
        "print(f\"\\nâœ“ Score separation: {separation:.1f} points\")\n",
        "if separation > 0:\n",
        "    print(f\"   â†’ Clear separation between classes (no overlap)\")\n",
        "else:\n",
        "    print(f\"   â†’ Some overlap between classes\")\n",
        "\n",
        "print(\"\\n\" + \"=\"*120)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "detailed_header"
      },
      "source": [
        "## Detailed Site Analysis: Cetuximab"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 19,
      "metadata": {
        "id": "detailed_cell",
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "outputId": "dfc39f13-064e-42c3-df71-3bbbe96e3805"
      },
      "outputs": [
        {
          "output_type": "stream",
          "name": "stdout",
          "text": [
            "==============================================================================================================\n",
            "CETUXIMAB - DETAILED SITE ANALYSIS\n",
            "==============================================================================================================\n",
            "\n",
            "Cetuximab has documented Fab glycosylation at N88 (IMGT 97) in VH FR3.\n",
            "This site was identified by van de Bovenkamp et al. as a key example\n",
            "of clinically relevant Fab glycosylation affecting immunogenicity.\n",
            "\n",
            "Overall Risk Level:   HIGH\n",
            "Overall Risk Score:   67.7\n",
            "Total Actual Sites:   2\n",
            "Total Progenitor Sites: 3\n",
            "\n",
            "--------------------------------------------------------------------------------------------------------------\n",
            "ALL SITES (sorted by risk contribution):\n",
            "--------------------------------------------------------------------------------------------------------------\n",
            "Chain   Pos   IMGT   Motif          Type               Region   X-Eff   Occup   Contrib  Risk\n",
            "--------------------------------------------------------------------------------------------------------------\n",
            "heavy   87    88     NDT            actual             FR3*     0.25    0.225   29.9     MEDIUM\n",
            "light   40    41     NGS            actual             FR2      0.80    0.256   28.1     MEDIUM\n",
            "heavy   82    83     NS[Lâ†’S/T]      progenitor_to_ST   FR3*     0.90    0.203   3.4      MEDIUM\n",
            "light   69    70     [Dâ†’N]FT        progenitor_D_to_N  FR3      0.55    0.124   3.2      LOW\n",
            "heavy   71    72     [Dâ†’N]NS        progenitor_D_to_N  FR3      0.50    0.045   3.1      LOW\n",
            "\n",
            "* = Vernier zone (IMGT 75-88)\n",
            "\n",
            "SCORE BREAKDOWN:\n",
            "  Actual sites (2):     58.0 points  (86%)\n",
            "  Progenitor sites (3): 9.7 points  (14%)\n",
            "  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\n",
            "  TOTAL:                67.7 points\n",
            "\n",
            "==============================================================================================================\n",
            "KEY INSIGHT: Actual N-X-S/T sites dominate the risk score, as designed.\n",
            "This is why Cetuximab scores HIGH while progenitor-only antibodies score LOW.\n",
            "==============================================================================================================\n"
          ]
        }
      ],
      "source": [
        "# ============================================================================\n",
        "# DETAILED ANALYSIS: CETUXIMAB (Known Glycosylated)\n",
        "# ============================================================================\n",
        "\n",
        "print(\"=\"*110)\n",
        "print(\"CETUXIMAB - DETAILED SITE ANALYSIS\")\n",
        "print(\"=\"*110)\n",
        "print()\n",
        "print(\"Cetuximab has documented Fab glycosylation at N88 (IMGT 97) in VH FR3.\")\n",
        "print(\"This site was identified by van de Bovenkamp et al. as a key example\")\n",
        "print(\"of clinically relevant Fab glycosylation affecting immunogenicity.\")\n",
        "print()\n",
        "\n",
        "cetuximab_result = all_results['Cetuximab']\n",
        "\n",
        "print(f\"Overall Risk Level:   {cetuximab_result['overall_risk_level']}\")\n",
        "print(f\"Overall Risk Score:   {cetuximab_result['overall_risk_score']:.1f}\")\n",
        "print(f\"Total Actual Sites:   {cetuximab_result['total_actual']}\")\n",
        "print(f\"Total Progenitor Sites: {cetuximab_result['total_progenitor']}\")\n",
        "print()\n",
        "\n",
        "print(\"-\"*110)\n",
        "print(\"ALL SITES (sorted by risk contribution):\")\n",
        "print(\"-\"*110)\n",
        "print(f\"{'Chain':<7} {'Pos':<5} {'IMGT':<6} {'Motif':<14} {'Type':<18} {'Region':<8} {'X-Eff':<7} {'Occup':<7} {'Contrib':<8} {'Risk'}\")\n",
        "print(\"-\"*110)\n",
        "\n",
        "for site in cetuximab_result['all_sites']:\n",
        "    vernier = '*' if site.in_vernier_zone else ' '\n",
        "    region_str = site.region + vernier\n",
        "    print(f\"{site.chain:<7} {site.position:<5} {site.imgt_position:<6} {site.motif:<14} \"\n",
        "          f\"{site.site_type:<18} {region_str:<8} {site.x_efficiency:<7.2f} \"\n",
        "          f\"{site.occupancy_score:<7.3f} {site.risk_contribution:<8.1f} {site.risk_level.value}\")\n",
        "\n",
        "print()\n",
        "print(\"* = Vernier zone (IMGT 75-88)\")\n",
        "print()\n",
        "\n",
        "# Score breakdown\n",
        "actual_sites = [s for s in cetuximab_result['all_sites'] if s.site_type == 'actual']\n",
        "prog_sites = [s for s in cetuximab_result['all_sites'] if s.site_type != 'actual']\n",
        "actual_contrib = sum(s.risk_contribution for s in actual_sites)\n",
        "prog_contrib = sum(s.risk_contribution for s in prog_sites)\n",
        "\n",
        "print(\"SCORE BREAKDOWN:\")\n",
        "print(f\"  Actual sites ({len(actual_sites)}):     {actual_contrib:.1f} points  ({actual_contrib/cetuximab_result['overall_risk_score']*100:.0f}%)\")\n",
        "print(f\"  Progenitor sites ({len(prog_sites)}): {prog_contrib:.1f} points  ({prog_contrib/cetuximab_result['overall_risk_score']*100:.0f}%)\")\n",
        "print(f\"  â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€\")\n",
        "print(f\"  TOTAL:                {cetuximab_result['overall_risk_score']:.1f} points\")\n",
        "\n",
        "print()\n",
        "print(\"=\"*110)\n",
        "print(\"KEY INSIGHT: Actual N-X-S/T sites dominate the risk score, as designed.\")\n",
        "print(\"This is why Cetuximab scores HIGH while progenitor-only antibodies score LOW.\")\n",
        "print(\"=\"*110)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {
        "id": "interpretation_header"
      },
      "source": [
        "## Interpretation\n",
        "\n",
        "### Why Low False Positive Rate?\n",
        "\n",
        "The validation shows near-perfect specificity (few false positives) because **FDA-approved therapeutics are survivors**. These antibodies have been through:\n",
        "\n",
        "1. **Humanization** â€” problematic sequences often removed\n",
        "2. **Developability screening** â€” glycosylation risks flagged early\n",
        "3. **Lead optimization** â€” liabilities engineered out\n",
        "4. **Manufacturing optimization** â€” clones with clean glycoprofiles selected\n",
        "\n",
        "The 16 \"non-glycosylated\" antibodies aren't random sequences â€” they're **curated winners**. Cetuximab is an exception where glycosylation was either:\n",
        "- Unavoidable for binding (the site is functionally constrained)\n",
        "- Acceptable given the clinical benefit\n",
        "\n",
        "### For ML-Designed Antibodies (RFdiffusion, etc.)\n",
        "\n",
        "This is where the scanner adds real value. ML tools don't have the selection pressure that shaped these FDA therapeutics. They can and do generate sequences with:\n",
        "- Actual N-X-S/T sites in CDRs\n",
        "- High-risk progenitor sites that could convert during development\n",
        "- Sites in Vernier zones that affect stability\n",
        "\n",
        "The scanner catches what evolution (and pharma development) would eventually remove â€” **but catches it at design time, not after years of development.**\n",
        "\n",
        "---\n",
        "\n",
        "### v3 Scoring Design Philosophy\n",
        "\n",
        "The scoring is deliberately **asymmetric**:\n",
        "\n",
        "| Site Type | Score Range | Rationale |\n",
        "|-----------|-------------|----------|\n",
        "| Actual CDR | 30-45 pts | Worst case: glycan in binding site |\n",
        "| Actual Vernier | 27-40 pts | Affects VH/VL packing |\n",
        "| Actual Framework | 25-37 pts | Still affects stability/immunogenicity |\n",
        "| Progenitor Dâ†’N | 3-10 pts | ~16% SHM conversion probability |\n",
        "| Progenitor â†’S/T | 2-7 pts | Lower conversion probability |\n",
        "\n",
        "This ensures antibodies with **actual sites score distinctly higher** than those with only progenitor risks.\n",
        "\n",
        "---\n",
        "\n",
        "**Repository:** [progenitor-glycosylation-scanner](https://github.com/AntibodyML/progenitor-glycosylation-scanner)  \n",
        "**Contact:** AntibodyML Consulting LLC\n",
        "LinkedIn: https://www.linkedin.com/in/gaughanchristopher/"
      ]
    },
    {
      "cell_type": "code",
      "source": [],
      "metadata": {
        "id": "eW0iMwfKXzrU"
      },
      "execution_count": null,
      "outputs": []
    }
  ],
  "metadata": {
    "kernelspec": {
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python",
      "version": "3.8.10"
    },
    "colab": {
      "provenance": [],
      "include_colab_link": true
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}